Back to Search
DR. BALAMURALI KRISHNA AMBATI MD
MD
Ophthalmology Physician
NPI: 1750397576IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
6771485-1205(UT)MD178830(OR)
Education
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Class of 1995
Research & Publications (20)
Inhibition of corneal neovascularization by genetic ablation of CCR2.
PMID 12827053·Cornea·2003
7-preclinical
Sustained inhibition of corneal neovascularization by genetic ablation of CCR5.
PMID 12556387·Invest Ophthalmol Vis Sci·2003
7-preclinical
Corneal transparency: genesis, maintenance and dysfunction.
PMID 19481138·Brain Res Bull·2010
6-review
Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium.
PMID 19608628·FASEB J·2009
7-preclinical
CCR3 is a target for age-related macular degeneration diagnosis and therapy.
PMID 19525930·Nature·2009
7-preclinical
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.
PMID 19668192·Nat Med·2009
7-preclinical
Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth.
PMID 19359485·Proc Natl Acad Sci U S A·2009
7-preclinical
Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.
PMID 19194480·Gene Ther·2009
7-preclinical
Corneal stroma PDGF blockade and myofibroblast development.
PMID 19133260·Exp Eye Res·2009
7-preclinical
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.
PMID 18368052·Nature·2008
7-preclinical
Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC protein.
PMID 17560152·J Mol Graph Model·2007
8-other
CXCR4 down-regulation by small interfering RNA inhibits invasion and tubule formation of human retinal microvascular endothelial cells.
PMID 17521613·Biochem Biophys Res Commun·2007
8-other
Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis.
PMID 17460257·Invest Ophthalmol Vis Sci·2007
7-preclinical
Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization.
PMID 17198016·Cornea·2007
7-preclinical
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.
PMID 17151056·Br J Ophthalmol·2007
8-other
Flt-1 intraceptor induces the unfolded protein response, apoptotic factors, and regression of murine injury-induced corneal neovascularization.
PMID 17065489·Invest Ophthalmol Vis Sci·2006
7-preclinical
Drusen complement components C3a and C5a promote choroidal neovascularization.
PMID 16452172·Proc Natl Acad Sci U S A·2006
7-preclinical
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
PMID 16453023·J Clin Invest·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 257 N 8th St
Cottage Grove, OR 97424 - Phone
- (541) 942-5000
Quick Facts
- NPI
- 1750397576
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile